Dr. Jonathan E. Brammer, MD
Claim this profileOhio State University Comprehensive Cancer Center
Area of expertise
Lymphoma
Jonathan E. Brammer, MD has run 4 trials for Lymphoma. Some of their research focus areas include:
Leukemia
Jonathan E. Brammer, MD has run 3 trials for Leukemia. Some of their research focus areas include:
Affiliated Hospitals
Ohio State University Comprehensive Cancer Center
The James Cancer Hospital And Solove Research Institute OSUCC
Clinical Trials Jonathan E. Brammer, MD is currently running
APG-115 + APG-2575
for Leukemia
This trial tests two experimental drugs, APG-115 and APG-2575, in patients with a rare type of leukemia called T-PLL. APG-115 aims to stop cancer cells from growing, while APG-2575 targets and kills cancer cells. The study will help determine if these drugs are safe and effective.
Recruiting
1 award
Phase 2
13 criteria
Ruxolitinib
for Large Granular Lymphocytic Leukemia
This trial tests if ruxolitinib can shrink tumors in patients with a specific type of leukemia called T-cell large granular lymphocyte leukemia. Ruxolitinib works by blocking enzymes that cancer cells need to grow. The goal is to see if this medication can help these patients when other treatments might not work. Ruxolitinib is an oral medication used to treat myelofibrosis and polycythemia vera, but its effects in these conditions are uncertain.
Recruiting
1 award
Phase 2
More about Jonathan E. Brammer, MD
Clinical Trial Related
4 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Jonathan E. Brammer, MD has experience with
- Prednisone
- Duvelisib
- Oral Azacitidine
- Ruxolitinib
- NEXI-001 T Cell Product
- Lenalidomide
Breakdown of trials Jonathan E. Brammer, MD has run
Lymphoma
Leukemia
Peripheral T-Cell Lymphoma
Large Granular Lymphocyte Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jonathan E. Brammer, MD specialize in?
Jonathan E. Brammer, MD focuses on Lymphoma and Leukemia. In particular, much of their work with Lymphoma has involved Stage IV patients, or patients who are CD3 positive.
Is Jonathan E. Brammer, MD currently recruiting for clinical trials?
Yes, Jonathan E. Brammer, MD is currently recruiting for 2 clinical trials in Columbus Ohio. If you're interested in participating, you should apply.
Are there any treatments that Jonathan E. Brammer, MD has studied deeply?
Yes, Jonathan E. Brammer, MD has studied treatments such as Prednisone, Duvelisib, Oral Azacitidine.
What is the best way to schedule an appointment with Jonathan E. Brammer, MD?
Apply for one of the trials that Jonathan E. Brammer, MD is conducting.
What is the office address of Jonathan E. Brammer, MD?
The office of Jonathan E. Brammer, MD is located at: Ohio State University Comprehensive Cancer Center, Columbus, Ohio 43210 United States. This is the address for their practice at the Ohio State University Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.